Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Treo Ventures, established in 2018, is a venture capital firm focused on medical device and digital health innovations that address significant unmet clinical needs. The firm operates from offices in Silicon Valley, California, and Dublin, Ireland. Founded by Mudit Jain, PhD, and Brad Vale, PhD, DVM, both of whom have extensive backgrounds in healthcare investing, Treo Ventures has collectively invested in over 40 companies globally.
The firm has a strong commitment to advancing medical technology, leveraging its experience to support transformative innovations. Treo Ventures operates the NuXcel medical device accelerator, which plays a crucial role in developing novel medical technologies. The firm has a notable portfolio of 10 companies, showcasing its focus on impactful healthcare solutions.
Treo Ventures invests primarily in medical technology companies that tackle large unmet clinical needs. Their investment strategy encompasses both early-stage investments, where feasibility has been demonstrated, and later-stage investments supported by clinical data. The firm targets opportunities in the United States and Europe, emphasizing innovations that can significantly improve patient outcomes.
Investment checks typically range from pre-seed to Series B stages, allowing Treo Ventures to support companies at various points in their development. The firm particularly values opportunities generated through its NuXcel accelerator, which fosters the growth of medical device innovations. Treo Ventures seeks founders who demonstrate a strong commitment to addressing clinical challenges and possess the capability to execute their vision effectively.
Treo Ventures has a diverse portfolio of notable companies, including:
Mudit K. Jain, PhD - General Partner. Mudit has a strong background in healthcare investing and has led numerous successful investments in medical technology.
Brad H. Vale, PhD, DVM - General Partner. Brad brings extensive experience in operational roles within the healthcare sector, contributing to Treo's strategic direction.
Tracy Pappas - General Partner. Tracy has a diverse background in venture capital and healthcare, focusing on identifying promising investment opportunities.
Dave Shanahan, BSc - Venture Partner. Dave specializes in medical technology and has a track record of supporting startups in the healthcare space.
To pitch Treo Ventures, founders should visit their website at treovp.com. The pitch deck should include a comprehensive overview of the technology, market analysis, and clinical need. Treo Ventures prefers clear and concise presentations that highlight the innovation's potential impact.
Response times may vary, but founders should expect to hear back within a few weeks. Warm introductions are encouraged, as they can facilitate the review process.
Treo Ventures operates the NuXcel medical device accelerator, which supports the development of novel medical technologies. The program is designed to help startups refine their products and navigate the complexities of the medical device landscape.
Eligibility for the NuXcel accelerator typically includes early-stage medical technology companies that demonstrate a strong potential for addressing unmet clinical needs. Interested startups can apply through the Treo Ventures website.
In recent months, Treo Ventures has continued to expand its portfolio, actively investing in companies that are innovating within the medical technology sector. Notable investments include advancements in neuromodulation therapy and ultrasound-based treatments.
The firm has also highlighted its commitment to supporting the NuXcel accelerator, which plays a crucial role in fostering the development of novel medical technologies. This accelerator has been instrumental in bringing innovative solutions to market.
What are Treo Ventures' investment criteria?
Treo Ventures focuses on medical technology companies that address significant unmet clinical needs. They invest in both early-stage and later-stage companies, emphasizing innovations with demonstrated feasibility and clinical data.
How can I apply or pitch to Treo Ventures?
Founders can pitch Treo Ventures through their website at treovp.com. It is advisable to include a clear description of the technology, market potential, and clinical need in the pitch deck.
What makes Treo Ventures different from other investors?
Treo Ventures has a specific focus on medical technology and operates the NuXcel accelerator, which supports the development of novel medical devices. Their expertise in healthcare investing sets them apart.
What is Treo Ventures' geographic scope?
The firm primarily invests in the United States and Europe, targeting companies that can address clinical needs in these regions.
What is Treo Ventures' typical fund size and check size?
Treo Ventures invests across various stages, from pre-seed to Series B, but specific fund sizes and check sizes are not publicly disclosed.
What kind of post-investment involvement does Treo Ventures have?
Treo Ventures actively supports its portfolio companies, particularly those in the NuXcel accelerator, by providing resources and guidance to help them succeed in the medical technology space.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.